Literature DB >> 11254581

Stage-dependent role of nitric oxide in control of Trypanosoma cruzi infection.

M Saeftel1, B Fleischer, A Hoerauf.   

Abstract

Trypanosoma cruzi, the causative agent of Chagas' disease, is known to be susceptible to nitric oxide (NO)-dependent killing by gamma interferon-activated macrophages. Mice deficient for inducible nitric oxide synthase (iNOS) are highly susceptible to T. cruzi, and inhibition of iNOS from the beginning of infection was reported to lead to an increase in trypomastigotes in the blood and to high mortality. In the present study, we investigated whether NO production is essential for the control of T. cruzi in all phases of the infection. BALB/c mice were treated at different time intervals after T. cruzi infection with an iNOS inhibitor, aminoguanidine or L-N6-(1-iminoethyl)-lysine (L-NIL). Treatment initiated with the beginning of the infection resulted in 100% mortality by day 16 postinfection (p.i.). If treatment was started later during the acute phase at the peak of parasitemia (day 20 p.i.), all the mice survived. Parasitemia was cleared and tissue amastigotes became undetectable in these mice even in the presence of the iNOS inhibitor L-NIL. Inhibition of iNOS in the chronic phase of the infection, i.e., from day 60 to day 120 p.i., with L-NIL did not result in a reappearance of parasitemia. These data suggest that while NO is essential for T. cruzi control in the early phase of acute infection, it is dispensable in the late acute and chronic phase, revealing a fundamental difference in control mechanisms compared to those in infections by other members of the order Kinetoplastida, e.g., Leishmania major.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11254581      PMCID: PMC98153          DOI: 10.1128/IAI.69.4.2252-2259.2001

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  33 in total

1.  Trypanosoma cruzi infection in MHC-deficient mice: further evidence for the role of both class I- and class II-restricted T cells in immune resistance and disease.

Authors:  R L Tarleton; M J Grusby; M Postan; L H Glimcher
Journal:  Int Immunol       Date:  1996-01       Impact factor: 4.823

2.  Peroxynitrite-mediated cytotoxicity to Trypanosoma cruzi.

Authors:  A Denicola; H Rubbo; D Rodríguez; R Radi
Journal:  Arch Biochem Biophys       Date:  1993-07       Impact factor: 4.013

3.  Xid-associated resistance to experimental Chagas' disease is IFN-gamma dependent.

Authors:  P Minoprio; M C el Cheikh; E Murphy; M Hontebeyrie-Joskowicz; R Coffman; A Coutinho; A O'Garra
Journal:  J Immunol       Date:  1993-10-15       Impact factor: 5.422

4.  Regulation of Trypanosoma cruzi infection in mice by gamma interferon and interleukin 10: role of NK cells.

Authors:  F Cardillo; J C Voltarelli; S G Reed; J S Silva
Journal:  Infect Immun       Date:  1996-01       Impact factor: 3.441

5.  Chagas' disease is attenuated in mice lacking gamma delta T cells.

Authors:  E C Santos Lima; P Minoprio
Journal:  Infect Immun       Date:  1996-01       Impact factor: 3.441

6.  Role of nitric oxide in resistance and histopathology during experimental infection with Trypanosoma cruzi.

Authors:  P Petray; E Castaños-Velez; S Grinstein; A Orn; M E Rottenberg
Journal:  Immunol Lett       Date:  1995 Jul-Aug       Impact factor: 3.685

7.  Possible role of nitric oxide in malarial immunosuppression.

Authors:  K A Rockett; M M Awburn; E J Rockett; W B Cowden; I A Clark
Journal:  Parasite Immunol       Date:  1994-05       Impact factor: 2.280

8.  Outcome of infection with different strains of Trypanosoma cruzi in mice lacking CD4 and/or CD8.

Authors:  M E Rottenberg; A Riarte; L Sporrong; J Altcheh; P Petray; A M Ruiz; H Wigzell; A Orn
Journal:  Immunol Lett       Date:  1995-02       Impact factor: 3.685

9.  Nitric oxide is involved in control of Trypanosoma cruzi-induced parasitemia and directly kills the parasite in vitro.

Authors:  G N Vespa; F Q Cunha; J S Silva
Journal:  Infect Immun       Date:  1994-11       Impact factor: 3.441

10.  Reactivation of latent leishmaniasis by inhibition of inducible nitric oxide synthase.

Authors:  S Stenger; N Donhauser; H Thüring; M Röllinghoff; C Bogdan
Journal:  J Exp Med       Date:  1996-04-01       Impact factor: 14.307

View more
  20 in total

1.  Pivotal role of interleukin-12 and interferon-gamma axis in controlling tissue parasitism and inflammation in the heart and central nervous system during Trypanosoma cruzi infection.

Authors:  V Michailowsky; N M Silva; C D Rocha; L Q Vieira; J Lannes-Vieira; R T Gazzinelli
Journal:  Am J Pathol       Date:  2001-11       Impact factor: 4.307

2.  Interaction of natural killer cells with Trypanosoma cruzi-infected fibroblasts.

Authors:  T Lieke; C Steeg; S E B Graefe; B Fleischer; T Jacobs
Journal:  Clin Exp Immunol       Date:  2006-08       Impact factor: 4.330

3.  High levels of interleukin-10 impair resistance to pulmonary coccidioidomycosis in mice in part through control of nitric oxide synthase 2 expression.

Authors:  Maria del Pilar Jimenez; Lorraine Walls; Joshua Fierer
Journal:  Infect Immun       Date:  2006-06       Impact factor: 3.441

4.  Impaired innate immunity in Tlr4(-/-) mice but preserved CD8+ T cell responses against Trypanosoma cruzi in Tlr4-, Tlr2-, Tlr9- or Myd88-deficient mice.

Authors:  Ana-Carolina Oliveira; Bruna C de Alencar; Fanny Tzelepis; Weberton Klezewsky; Raquel N da Silva; Fabieni S Neves; Gisele S Cavalcanti; Silvia Boscardin; Marise P Nunes; Marcelo F Santiago; Alberto Nóbrega; Maurício M Rodrigues; Maria Bellio
Journal:  PLoS Pathog       Date:  2010-04-29       Impact factor: 6.823

5.  Chemoprevention of Colon Cancer by iNOS-Selective Inhibitors.

Authors:  Naveena B Janakiram; Chinthalapally V Rao
Journal:  For Immunopathol Dis Therap       Date:  2012-01-01

6.  Cyclic AMP decreases the production of NO and CCL2 by macrophages stimulated with Trypanosoma cruzi GPI-mucins.

Authors:  Andre Talvani; Sibele Ferreira Coutinho; Luciola da Silva Barcelos; Mauro Martins Teixeira
Journal:  Parasitol Res       Date:  2008-12-18       Impact factor: 2.289

7.  Does cyclophosphamide play a protective role against neuronal loss in chronic T. cruzi infection?

Authors:  Leony Cristina Caetano; Sérgio Zucoloto; Laura Midori Kawasse; Miriam Paula Alonso Toldo; José Clóvis do Prado
Journal:  Dig Dis Sci       Date:  2008-04-22       Impact factor: 3.199

8.  Perforin-expressing cytotoxic cells contribute to chronic cardiomyopathy in Trypanosoma cruzi infection.

Authors:  Jaline Coutinho Silverio; Luzia Maria de-Oliveira-Pinto; Andréa Alice da Silva; Gabriel Melo de Oliveira; Joseli Lannes-Vieira
Journal:  Int J Exp Pathol       Date:  2009-10-28       Impact factor: 1.925

9.  Resistant mice lacking interleukin-12 become susceptible to Trypanosoma cruzi infection but fail to mount a T helper type 2 response.

Authors:  Ana Paula Galvão Da Silva; Jacqueline F Jacysyn; Ises De Almeida Abrahamsohn
Journal:  Immunology       Date:  2003-02       Impact factor: 7.397

10.  Inducible nitric oxide synthase is not essential for control of Trypanosoma cruzi infection in mice.

Authors:  Kara L Cummings; Rick L Tarleton
Journal:  Infect Immun       Date:  2004-07       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.